# EDGAR Filing Document

**Accession Number:** 0001047862
**File Stem:** 0001047862-23-000069
**Filing Date:** 2023-2
**Character Count:** 10785
**Document Hash:** 0694a7586acef4979e747d79c3a3130a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001047862-23-000069.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0001047862-23-000069

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230215

**FILED AS OF DATE**: 20230217

**DATE AS OF CHANGE**: 20230217

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Noyes Mark
- **CENTRAL INDEX KEY:** 0001691193

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14514
- **FILM NUMBER:** 23644745

**MAIL ADDRESS:**
- **STREET 1:** 4 IRVING PLACE
- **STREET 2:** ROOM 1450-S
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10003
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CONSOLIDATED EDISON INC
- **CENTRAL INDEX KEY:** 0001047862
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRIC & OTHER SERVICES COMBINED [4931]
- **IRS NUMBER:** 133965100
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4 IRVING PLACE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10003
- **BUSINESS PHONE:** 8005225635

**MAIL ADDRESS:**
- **STREET 1:** 4 IRVING PLACE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10003

## Ex-24

```
<pre>Power of Attorney

Effective immediately, the undersigned hereby constitutes and appoints each of

Deneen L. Donnley, Sylvia V. Dooley, Monica Janairo, Vanessa M. Franklin, and

Michele M. Weber, or any of them signing singly, and with full power of

substitution, the undersigned's true and lawful attorney-in-fact to:

execute for and on behalf of the undersigned, in the undersigned's

capacity as an officer of Consolidated Edison, Inc. or its subsidiaries

(the "Company"), Forms ID, 3, 4 and 5 (collectively, the "Forms") in

accordance with Section 16(a) of the Securities Exchange Act of 1934

(the "Exchange Act") and the rules thereunder;

do and perform any and all acts for and on behalf of the undersigned which

may be necessary or desirable to complete and execute any such Forms,

complete and execute any amendment or amendments thereto, and timely

file such Forms with the United States Securities and Exchange Commission

and any stock exchange or similar authority; and

take any other action of any type whatsoever in connection with the foregoing

which, in the opinion of such attorney-in-fact, may be of benefit to, in the

best interest of, or legally required by, the undersigned, it being understood

that the documents executed by such attorney-in-fact on behalf of the

undersigned pursuant to this Power of Attorney shall be in such form and shall

contain such terms and conditions as such attorney-in-fact may approve

in such attorney-in-fact's discretion.

Effective immediately, the undersigned hereby grants to each such

attorney-in-fact full power and authority to do and perform any and every

act and thing whatsoever requisite, necessary, or proper to be done in the

exercise of any of the rights and powers herein granted, as fully to all

intents and purposes as the undersigned might or could do if personally

present, with full power o substitution or revocation, hereby ratifying

and confirming all that such attorney-in-fact, or such attorney-in-fact's

substitute or substitutes, shall lawfully do or cause to be done by virtue of

this power of attorney and the rights and powers herein granted.

The undersigned acknowledges that the foregoing attorneys-in-fact, in

 serving in such capacity at the  request of the undersigned, are not

assuming, nor is the Company assuming, any of the undersigned's

responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms with respect to the

undersigned's holdings of and transactions in securities issued by

the Company, unless earlier revoked by the undersigned in a signed

writing delivered to the foregoing attorneys-in-fact. Effective immediately,

the undersigned hereby revokes all previously executed powers of attorney

relating to the Forms.

IN WITNESS WHEREOF, the undersigned has caused this

Power of Attorney to be executed as of this 24 day of February 2020.

/s/  Mark Noyes

Mark Noyes

</pre>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Noyes Mark<br><sub>(Last) (First) (Middle)</sub><br>CONSOLIDATED EDISON, INC. C/O SECRETARY<br>4 IRVING PLACE; ROOM 16 - 205<br><sub>(Street)</sub><br>NEW YORK, NY 10003<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President & CEO, CECEB_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CONSOLIDATED EDISON INC [ ED ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-02-15 |  | M |  | 11079.000<sup>(1)</sup> | A | <sup>(1)</sup> | 27884.922<sup>(1)(2)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 19.485<sup>(3)</sup> | I | By Tax Reduction Act Stock Ownership Plan (TRASOP) |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Performance Units | <sup>(1)</sup> | 2023-02-15 |  | M |  |  | 11079 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 11079 | <sup>(1)</sup> | 0 | D |  |
| Performance Units | <sup>(4)</sup> | 2023-02-15 |  | A |  | 7700 |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 7700 | <sup>(4)</sup> | 7700 | D |  |
| Time-Based Restricted Stock Units | <sup>(5)</sup> | 2023-02-15 |  | A |  | 3300 |  | 2025-12-31 | 2025-12-31 | Common Stock | 3300 | <sup>(5)</sup> | 3300 | D |  |

---

### Footnotes:

(1) Represents Performance Units granted in 2020 under the Long Term Incentive Plan of the Company (the ("LTIP") that vested for which the reporting person elected to defer shares until a later date.  The number of shares has been adjusted from the original reporting based upon the achievement of the performance criteria.  Each Performance Unit is the economic equivalent of one share of Company common stock.

(2) Total includes  75.740,  146.053, 130.859, and 133.943 Deferred Stock Units ("DSUs") acquired on March 15, 2022, June 15, 2022 and September 15, 2022, and December 15, 2022  respectively pursuant to the LTIP dividend reinvestment provision. Each DSU represents one share of the Company's common stock.

(3) Between 2/17/22 and 01/31/23 the reporting person acquired 0.632 shares of Company common stock under the TRASOP.  The information in this report is based on a TRASOP plan statement dated as of 01/31/23.

(4) Represents a grant of Performance Units granted under the LTIP scheduled to vest in 2026 upon the determination of the performance criteria by the Management, Development and Compensation Committee of the  Board of Directors of the Company. Each Performance Unit is the economic equivalent of one share of Company common stock. The number of shares (or cash equivalents) ultimately received will be adjusted and determined based upon the achievement of the performance criteria.

(5) Represents a grant of time-based restricted stock units granted under the LTIP scheduled to vest in full on December 31, 2025.  Each time-based restricted stock unit is a contingent right to receive one share of Company common stock.

**Signature:** William J. Kelleher; Attorney-in-Fact  
**Date:** 2023-02-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**